Skip to main content
Perk Labs Inc. logo

Perk Labs Inc. — Investor Relations & Filings

Ticker · PKLBF ISIN · CA71401N1050 LEI · 549300JKU1DQU5D63Q24 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 583 across all filing types
Latest filing 2021-02-17 Capital/Financing Update
Country CA Canada
Listing CSE PKLBF

About Perk Labs Inc.

http://perklabs.io

Perk Labs Inc. is a financial technology company that develops and operates mobile ordering, payment, and loyalty platforms. Through its core product, Perk Hero, the company provides restaurateurs and businesses with digital tools, including QR code-powered digital dine-in, commission-free mobile ordering, and a gamified loyalty program, aimed at improving customer engagement and operational efficiency. Perk Labs employs a Digital Franchising model to scale its software-as-a-service (SaaS) platform across new markets by partnering with local entrepreneurs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the renewal of an At-the-Market (ATM) equity program by Perk Labs Inc. It details the terms of the ATM program, the amount of shares to be issued, the intended use of proceeds, and references the prospectus supplement and base shelf prospectus filed with Canadian securities regulators. There are no financial statements, earnings data, or detailed financial analysis present. The document is an update on capital raising activities, specifically the renewal of an equity financing program. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. The document length is sufficient and contains substantive information about financing activities, not just an announcement of a report publication or a certification. Therefore, the appropriate classification is CAP with high confidence.
2021-02-17 English
Other material contract(s).pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Equity Distribution Agreement' and is an execution copy dated February 17, 2021. It references a Short Form Base Shelf Prospectus and discusses terms related to an 'at-the-market distribution' (ATM) plan for the sale of common shares. The content is a legal and financial agreement outlining the terms and conditions for equity distribution, including definitions, regulatory references, and procedural details. It is not a financial report, earnings release, or management discussion. It is clearly related to capital raising activities through equity distribution. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-02-17 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from an auditor (Saturna Group Chartered Professional Accountants LLP) addressed to multiple Canadian securities commissions. It references a prospectus supplement dated February 17, 2021, related to a short form base shelf prospectus for Perk Labs Inc. The letter provides the auditor's consent to the use of their audit report dated March 30, 2020, on the company's consolidated financial statements for the years ended November 30, 2019 and 2018. The letter explicitly states that the auditor's consent is for incorporation by reference in the prospectus and clarifies that this consent does not constitute an audit or review of the prospectus itself. The document is short (2410 characters) and is primarily an auditor's consent letter related to a securities offering document, not the audit report itself or a full financial report. According to the rules, such a certification or consent letter should be classified as a Regulatory Filing (RNS) rather than an Audit Report (AR) or Annual Report (10-K).
2021-02-17 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm providing consent and confirming the accuracy of legal and tax advice referenced in a prospectus supplement related to an at-the-market offering of common shares. It is addressed to multiple securities commissions and references a prospectus supplement dated the same day. The content is legal consent and confirmation rather than the prospectus supplement itself or detailed financial data. The document length is short (2036 characters), and it does not contain financial statements or substantive financial data. Therefore, it is not a full Capital/Financing Update report but rather a regulatory filing related to the prospectus supplement. According to the rules, such legal consents and confirmations fall under Regulatory Filings (RNS).
2021-02-17 English
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a legal consent letter from Goodmans LLP regarding a Prospectus Supplement dated February 17, 2021, related to a Short Form Base Shelf Prospectus dated July 17, 2020. It is addressed to multiple Canadian securities commissions and confirms the law firm's consent to the use of their legal opinions in the Supplement. The document does not contain financial data, audit information, or detailed report content but is a legal attestation related to a financing prospectus. Given its nature as a legal consent letter and the absence of substantive financial or report data, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2021-02-17 English
Prospectus (non pricing) supplement (ATM) – English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled as a "Prospectus Supplement" related to a "Short Form Base Shelf Prospectus" and discusses the offering of common shares by Perk Labs Inc. It details the terms of a securities offering, including the amount to be raised, the distribution agreement, agent fees, risk factors, and legal notices. The document is clearly a formal offering document used to raise capital through the issuance of shares. This fits the definition of a Capital/Financing Update, which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the offering, not just an announcement or a brief summary. Therefore, it is not a Report Publication Announcement or Regulatory Filing. It is not an Annual Report, Earnings Release, or any other category related to financial results or governance. The key indicators are the terms "Prospectus Supplement," "Offering," "Distribution Agreement," and detailed terms of share issuance and agent compensation, all pointing to a Capital/Financing Update.
2021-02-17 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.